Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.

Bria E, Milella M, Sperduti I, Alessandrini G, Visca P, Corzani F, Giannarelli D, Cerasoli V, Cuppone F, Cecere FL, Marchetti A, Sacco R, Mucilli F, Malatesta S, Guetti L, Vitale L, Ceribelli A, Rinaldi M, Terzoli E, Cognetti F, Facciolo F.

Lung Cancer. 2009 Dec;66(3):365-71. doi: 10.1016/j.lungcan.2009.02.024. Epub 2009 Mar 27.

PMID:
19327866
2.

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.

Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Chinese.

PMID:
21914316
3.

Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.

Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M; Japan Clinical Oncology Group.

Lung Cancer. 2001 Oct;34(1):29-36.

PMID:
11557110
4.

Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.

Lee JG, Lee CY, Park IK, Kim DJ, Park SY, Kim KD, Chung KY.

Ann Thorac Surg. 2008 Jan;85(1):211-5.

PMID:
18154813
5.

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT.

Gynecol Oncol. 2006 Jul;102(1):92-7. Epub 2006 Jan 10.

PMID:
16406063
6.

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese.

PMID:
18353207
8.

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.

Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D.

J Thorac Cardiovasc Surg. 2002 Mar;123(3):466-73; discussion 473-4.

9.

N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.

Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.

Ann Surg Oncol. 2008 Jan;15(1):310-5. Epub 2007 Nov 7.

PMID:
17987346
10.

Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.

Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM.

Cancer. 2009 Feb 15;115(4):851-8. doi: 10.1002/cncr.23985.

11.

Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.

Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):87-91.

12.

Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Höfler H, Nekarda H, Siewert JR.

Ann Surg. 2008 Dec;248(6):968-78. doi: 10.1097/SLA.0b013e318190eddc.

PMID:
19092341
13.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
14.

[Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].

Zhang GQ, Han F, Gao SL, A DL, Pang ZL.

Ai Zheng. 2007 May;26(5):519-23. Chinese.

PMID:
17672944
15.

Survival and risk model for stage IB non-small cell lung cancer.

Padilla J, Calvo V, Peñalver JC, Zarza AG, Pastor J, Blasco E, París F.

Lung Cancer. 2002 Apr;36(1):43-8.

PMID:
11891032
16.

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr.

J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43.

17.

The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung.

Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, McKenna RJ.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):551-7.

18.

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T.

J Natl Cancer Inst. 2007 Jun 6;99(11):858-67.

PMID:
17551146
19.

[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].

Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. German.

PMID:
17109272
20.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407

Supplemental Content

Support Center